methamphetamine has been researched along with n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, ME; Dean, AC; Hsu, E; Ishibashi, K; London, ED; Mandelkern, MA; Monterosso, JR; Robertson, CL | 1 |
| Kato, K; Kunugi, H; Ogawa, S; Ota, M; Wakabayashi, C | 1 |
| Dean, AC; Kohno, M; London, ED; Mandelkern, MA; Morales, AM; Robertson, CL | 1 |
| Kato, K; Kunugi, H; Masuda, C; Ogawa, S; Ota, M | 1 |
| Ghahremani, DG; London, ED; Mandelkern, MA; Okita, K; Payer, DE; Robertson, CL | 1 |
| Dean, AC; Ghahremani, DG; London, ED; Mandelkern, MA; Okita, K; Payer, DE; Robertson, CL | 1 |
6 other study(ies) available for methamphetamine and n-((1-allyl-2-pyrrolidinyl)methyl)-5-(3-fluoropropyl)-2,3-dimethoxybenzamide
| Article | Year |
|---|---|
Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence.
Topics: Adult; Amphetamine-Related Disorders; Benzamides; Central Nervous System Stimulants; Corpus Striatum; Diagnostic and Statistical Manual of Mental Disorders; Dopamine; Female; Fluorine Radioisotopes; Humans; Male; Methamphetamine; Middle Aged; Positron-Emission Tomography; Receptors, Dopamine D2; Receptors, Dopamine D3; Reward; Surveys and Questionnaires; Young Adult | 2015 |
Methamphetamine-sensitized rats show augmented dopamine release to methylphenidate stimulation: a positron emission tomography using [18F]fallypride.
Topics: Animals; Benzamides; Biomarkers; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dopamine; Humans; Male; Methamphetamine; Methylphenidate; Positron-Emission Tomography; Rats; Receptors, Dopamine D2; Schizophrenia | 2015 |
Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users.
Topics: Benzamides; Dopamine Antagonists; Drug-Seeking Behavior; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mesencephalon; Methamphetamine; Positron-Emission Tomography; Protein Binding; Receptors, Dopamine D2; Regression Analysis; Substance-Related Disorders; Time Factors | 2015 |
Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [(18)F]fallypride.
Topics: Animals; Benzamides; Brain; Callithrix; Central Nervous System Stimulants; Cerebellum; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Fluorodeoxyglucose F18; Male; Methamphetamine; Methylphenidate; Positron-Emission Tomography; Prefrontal Cortex; Receptors, Dopamine D2; Receptors, Dopamine D3; Schizophrenia | 2015 |
Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals.
Topics: Adolescent; Adult; Affective Symptoms; Amphetamine-Related Disorders; Benzamides; Case-Control Studies; Central Nervous System Stimulants; Cerebral Cortex; Emotions; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Positron-Emission Tomography; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Synaptic Transmission; Young Adult | 2016 |
Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users.
Topics: Adult; Amphetamine-Related Disorders; Amygdala; Benzamides; Case-Control Studies; Diagnostic and Statistical Manual of Mental Disorders; Dopamine; Emotions; Female; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radioligand Assay; Receptors, Dopamine D2 | 2016 |